SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: squetch who wrote (19383)4/21/1998 5:53:00 PM
From: Flagrante Delictu  Respond to of 32384
 
Squetch, OFF TOPIC, Re: marvelling at nature. It must be very difficult not to transpose some of the words in recalling the nature show.

<< General Poster Session: Head & Neck Cancer >> I understand President Clinton is strongly in favor of programs to root out the latter.



To: squetch who wrote (19383)4/22/1998 7:39:00 AM
From: Henry Niman  Respond to of 32384
 
Still lots of room for improvement on the cancer front:
Tuesday April 21 6:28 PM EDT

Cancer Rates And Mortality Data Released

NEW YORK (Reuters) -- The rates of new cases of cancer and deaths from cancer decreased in the US and Canada
between 1990-1994, a report suggests, but researchers say much can still be done to save lives.

To put the figures in perspective, researchers at the North American Association of Central Cancer Registries (NAACCR) say
the total number of people in the US who died from cancer during the study period "...was equivalent to about one Titanic
sinking every day (and that) deaths from lung cancer alone in the US during this study period were equivalent to 12 jumbo jet
crashes every week." In Canada each year, "...cancer claimed more lives than the entire populations of the British Columbia
communities of Anmore, Lions Bay and New Westminster combined," the authors explain.

The NAACCR compiled statistics from cancer registries in 40 US states and regions and 12 Canadian provinces and
territories. Their report, "Cancer in North America 1990-1994" was presented Tuesday at the NAACCR annual meeting in
Vancouver.

The data show that 2,604,650 people in the US died from cancer between 1990-1994, with more men (53%) than women
(47%) affected. The most common cancer deaths were due to cancer of the lung (728,641), colon and rectum (285,724),
breast (218,786), and prostate (169,943).

US blacks had higher cancer rates than Caucasians for multiple myeloma and for cancers of the lung, oral cavity, prostate,
esophagus, stomach, and larynx. US Caucasians had higher rates for cancers of the urinary bladder, brain and central nervous
system, testis, and for lymphomas and leukemias. "The incidence rate for all cancers combined was 20% higher among US
black males than US Caucasian males (while) the incidence rate for all cancers combined was 5% higher for US white females
than US black females," the investigators report.

Among US women, the most common cancers were of the breast (31%), lung (12%), colon and rectum (12%), uterus (6%),
and ovary (4%). The five most common for US men were cancers of the prostate (31%), lung (16%), colon and rectum
(11%), urinary bladder (6%), and also non-Hodgkin's lymphoma (4%).

Leukemias, lymphomas, and cancers of the central nervous system accounted for 60% of pediatric cancers in the US, where
rates were 35% higher for Caucasians than blacks and more common among boys than girls.

In Canada, a total of 274,742 people died from cancer during 1990-1994, again with more men (55%) than women (45%)
affected. The most common cancer deaths among all Canadians, and among groups such as Canadian men, women and
children, were the same cancers, in order, as reported in the US.

"The published statistics are not just numbers. They represent our family members and friends," said Dr. Vivien Chen,
editor-in-chief of the reports. "It is the NAACCR's goal that this wealth of data be used to better understand the cancer
problem, to plan and develop appropriate cancer prevention and control programs, to stimulate research and, ultimately, to
reduce cancer risks and deaths in North America."



To: squetch who wrote (19383)4/22/1998 7:47:00 AM
From: Henry Niman  Respond to of 32384
 
The session on cancer prevention should also be of interest:
Molecular Targets of Chemoprevention

Saturday, May 16, 1998
9:35 AM - 10:50 AM

Sunday, May 17, 1998
8:00 AM - 9:15 AM

Waun Ki Hong, MD, Chair
UT MD Anderson Cancer Center

Ethan Dmitrovsky, MD
Memorial Sloan-Kettering Cancer Center

Raymond Dubois, MD, PhD
Vanderbilt Cancer Center

C. Kent Osborne, MD
UT Health Science Center at San Antonio

Recent advances in our understanding of the molecular mechanisms of
carcinogenesis have led to the synthesis of new drugs that inhibit tumor
development and selective action on specific molecular targets, such as
retinoid receptors, inducible COX-2 and estrogen receptor modulators. At the
conclusion of this session, the participant should be able to discuss the latest
advances in our understanding of the molecular and genetic fingerprints of
tumorgenesis in breast, colon and aerodigestive cancers and determine the
implications of their use as molecular targets for preventive therapy.